Cargando…
Maximizing the benefits of antiretroviral therapy for key affected populations
INTRODUCTION: Scientific research has demonstrated the clinical benefits of earlier initiation of antiretroviral treatment (ART), and that ART can markedly reduce HIV transmission to sexual partners. Ensuring universal access to ART for those who need it has long been a core principle of the HIV res...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International AIDS Society
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104298/ https://www.ncbi.nlm.nih.gov/pubmed/25043380 http://dx.doi.org/10.7448/IAS.17.1.19320 |
_version_ | 1782327245049692160 |
---|---|
author | Grubb, Ian R Beckham, Sarah W Kazatchkine, Michel Thomas, Ruth M Albers, Eliot R Cabral, Mauro Lange, Joep Vella, Stefano Kurian, Manoj Beyrer, Chris |
author_facet | Grubb, Ian R Beckham, Sarah W Kazatchkine, Michel Thomas, Ruth M Albers, Eliot R Cabral, Mauro Lange, Joep Vella, Stefano Kurian, Manoj Beyrer, Chris |
author_sort | Grubb, Ian R |
collection | PubMed |
description | INTRODUCTION: Scientific research has demonstrated the clinical benefits of earlier initiation of antiretroviral treatment (ART), and that ART can markedly reduce HIV transmission to sexual partners. Ensuring universal access to ART for those who need it has long been a core principle of the HIV response, and extending the benefits of ART to key populations is critical to increasing the impact of ART and the overall effectiveness of the HIV response. However, this can only be achieved through coordinated efforts to address political, social, legal and economic barriers that key populations face in accessing HIV services. DISCUSSION: Recent analyses show that HIV prevalence levels among key populations are far higher than among the general population, and they experience a range of biological and behavioural factors, and social, legal and economic barriers that increase their vulnerability to HIV and have resulted in alarmingly low ART coverage. World Health Organization 2014 consolidated guidance on HIV among key populations offers the potential for increased access to ART by key populations, following the same principles as for the general adult population. However, it should not be assumed that key populations will achieve greater access to ART unless stigma, discrimination and punitive laws, policies and practices that limit access to ART and other HIV interventions in many countries are addressed. CONCLUSIONS: Rights-based approaches and investments in critical enablers, such as supportive legal and policy environments, are essential to enable wider access to ART and other HIV interventions for key populations. The primary objective of ART should always be to treat the person living with HIV; prevention is an important, additional benefit. ART should be provided only with informed consent. The preventive benefits of treatment must not be used as a pretext for failure to provide other necessary HIV programming for key populations, including comprehensive harm reduction and other prevention interventions tailored to meet the needs of key populations. An end to AIDS is only possible if we overcome the barriers of criminalization, stigma and discrimination that remain key drivers of the HIV epidemics among key populations. |
format | Online Article Text |
id | pubmed-4104298 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | International AIDS Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-41042982014-07-21 Maximizing the benefits of antiretroviral therapy for key affected populations Grubb, Ian R Beckham, Sarah W Kazatchkine, Michel Thomas, Ruth M Albers, Eliot R Cabral, Mauro Lange, Joep Vella, Stefano Kurian, Manoj Beyrer, Chris J Int AIDS Soc Commentary INTRODUCTION: Scientific research has demonstrated the clinical benefits of earlier initiation of antiretroviral treatment (ART), and that ART can markedly reduce HIV transmission to sexual partners. Ensuring universal access to ART for those who need it has long been a core principle of the HIV response, and extending the benefits of ART to key populations is critical to increasing the impact of ART and the overall effectiveness of the HIV response. However, this can only be achieved through coordinated efforts to address political, social, legal and economic barriers that key populations face in accessing HIV services. DISCUSSION: Recent analyses show that HIV prevalence levels among key populations are far higher than among the general population, and they experience a range of biological and behavioural factors, and social, legal and economic barriers that increase their vulnerability to HIV and have resulted in alarmingly low ART coverage. World Health Organization 2014 consolidated guidance on HIV among key populations offers the potential for increased access to ART by key populations, following the same principles as for the general adult population. However, it should not be assumed that key populations will achieve greater access to ART unless stigma, discrimination and punitive laws, policies and practices that limit access to ART and other HIV interventions in many countries are addressed. CONCLUSIONS: Rights-based approaches and investments in critical enablers, such as supportive legal and policy environments, are essential to enable wider access to ART and other HIV interventions for key populations. The primary objective of ART should always be to treat the person living with HIV; prevention is an important, additional benefit. ART should be provided only with informed consent. The preventive benefits of treatment must not be used as a pretext for failure to provide other necessary HIV programming for key populations, including comprehensive harm reduction and other prevention interventions tailored to meet the needs of key populations. An end to AIDS is only possible if we overcome the barriers of criminalization, stigma and discrimination that remain key drivers of the HIV epidemics among key populations. International AIDS Society 2014-07-18 /pmc/articles/PMC4104298/ /pubmed/25043380 http://dx.doi.org/10.7448/IAS.17.1.19320 Text en © 2014 Grubb IR et al; licensee International AIDS Society http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Commentary Grubb, Ian R Beckham, Sarah W Kazatchkine, Michel Thomas, Ruth M Albers, Eliot R Cabral, Mauro Lange, Joep Vella, Stefano Kurian, Manoj Beyrer, Chris Maximizing the benefits of antiretroviral therapy for key affected populations |
title | Maximizing the benefits of antiretroviral therapy for key affected populations |
title_full | Maximizing the benefits of antiretroviral therapy for key affected populations |
title_fullStr | Maximizing the benefits of antiretroviral therapy for key affected populations |
title_full_unstemmed | Maximizing the benefits of antiretroviral therapy for key affected populations |
title_short | Maximizing the benefits of antiretroviral therapy for key affected populations |
title_sort | maximizing the benefits of antiretroviral therapy for key affected populations |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104298/ https://www.ncbi.nlm.nih.gov/pubmed/25043380 http://dx.doi.org/10.7448/IAS.17.1.19320 |
work_keys_str_mv | AT grubbianr maximizingthebenefitsofantiretroviraltherapyforkeyaffectedpopulations AT beckhamsarahw maximizingthebenefitsofantiretroviraltherapyforkeyaffectedpopulations AT kazatchkinemichel maximizingthebenefitsofantiretroviraltherapyforkeyaffectedpopulations AT thomasruthm maximizingthebenefitsofantiretroviraltherapyforkeyaffectedpopulations AT alberseliotr maximizingthebenefitsofantiretroviraltherapyforkeyaffectedpopulations AT cabralmauro maximizingthebenefitsofantiretroviraltherapyforkeyaffectedpopulations AT langejoep maximizingthebenefitsofantiretroviraltherapyforkeyaffectedpopulations AT vellastefano maximizingthebenefitsofantiretroviraltherapyforkeyaffectedpopulations AT kurianmanoj maximizingthebenefitsofantiretroviraltherapyforkeyaffectedpopulations AT beyrerchris maximizingthebenefitsofantiretroviraltherapyforkeyaffectedpopulations AT maximizingthebenefitsofantiretroviraltherapyforkeyaffectedpopulations |